Tetrazine-trans-cyclooctene ligated lanthanide conjugates for biomedical imaging

Hongxuan Chen, William Lim Kee Chang, Grace T. McMullon, Yichao Yu, Benjamin P. Woolley, Gráinne Geoghegan, Ceren Yalcin, Sophie V. Morse, Mark F. Lythgoe, James J. Choi and Nicholas J. Long

Inorg. Chem. Front., 2026, 13, 63
DOI: 10.1039/D5QI01745A

Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine

Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M. Bucher, Eva Schlein, Lorenzo J. I. Balestri, Luke R. Odell, Dag Sehlin and Stina Syvänen

Transl Neurodegener, 2025, 14
DOI: 10.1186/s40035-025-00532-2

Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model

Lennart Bohrmann, Christian B. M. Poulie, Cristina Rodríguez-Rodríguez, Stoyan Karagiozov, Katayoun Saatchi, Matthias M. Herth, Urs O. Häfeli and Roy P. Planalp

PLoS ONE, 2024, 19, e0300466
DOI: 10.1371/journal.pone.0300466

Preclinical Evaluation of Novel PET Probes for Dementia

Romy Cools, Kobe Kerkhofs, Renan C.F. Leitao and Guy Bormans

Seminars in Nuclear Medicine, 2023, 53, 599
DOI: 10.1053/j.semnuclmed.2023.03.004

Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology

Eva Schlein, Sara Lopes van den Broek, Tiffany Dallas, Ken G. Andersson, Stina Syvänen, Jonas Eriksson and Dag Sehlin

ACS Pharmacol. Transl. Sci., 2025, 8, 2804
DOI: 10.1021/acsptsci.5c00359

Toward Realization of Bioorthogonal Chemistry in the Clinic

Kim E. de Roode, Raffaella Rossin and Marc S. Robillard

Top Curr Chem (Z), 2025, 383
DOI: 10.1007/s41061-025-00495-y

An 211At-labeled Tetrazine for Pretargeted Therapy

Matthias M. Herth, Lars Hvass, Christian B. M. Poulie, Marius Müller, Rocio García-Vázquez, Tobias Gustavsson, Vladimir Shalgunov, Anne S. Clausen, Jesper T. Jørgensen, Ellinor Hansson, Holger Jensen, Emma Aneheim, Sture Lindegren, Andreas Kjaer and Umberto M. Battisti

J. Med. Chem., 2025, 68, 4410
DOI: 10.1021/acs.jmedchem.4c02281

A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points

Swarbhanu Sarkar, Jonathan M. Pham, Kimberly J. Edwards, Nitika Sharma, Kexiang Xu, A. Paden King, Andres Fernandez del Castillo, Michael D. Farwell, Daniel A. Pryma, Stephen J. Schuster and Mark A. Sellmyer

EJNMMI Res, 2025, 15
DOI: 10.1186/s13550-025-01213-x

Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of trans-Cyclooctene-Functionalized Molecular Spherical Nucleic Acids

Tatsiana Auchynnikava, Antti Äärelä, Heidi Liljenbäck, Juulia Järvinen, Putri Andriana, Luciana Kovacs, Jarkko Rautio, Johan Rajander, Pasi Virta, Anne Roivainen, Xiang-Guo Li and Anu J. Airaksinen

ACS Omega, 2023, 8, 45326
DOI: 10.1021/acsomega.3c04041

Utilizing machine learning techniques to predict the blood-brain barrier permeability of compounds detected using LCQTOF-MS in Malaysian Kelulut honey

R. Edros, T.W. Feng and R.H. Dong

SAR and QSAR in Environmental Research, 2023, 34, 475
DOI: 10.1080/1062936X.2023.2230868

Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET

Eva Schlein, Johanna Rokka, Luke R. Odell, Sara Lopes van den Broek, Matthias M. Herth, Umberto M. Battisti, Stina Syvänen, Dag Sehlin and Jonas Eriksson

EJNMMI radiopharm. chem., 2024, 9
DOI: 10.1186/s41181-024-00250-6

Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein

Sara Lopes van den Broek, Rocío García-Vázquez, Ida Vang Andersen, Guillermo Valenzuela-Nieto, Vladimir Shalgunov, Umberto M. Battisti, David Schwefel, Naphak Modhiran, Vasko Kramer, Yorka Cheuquemilla, Ronald Jara, Constanza Salinas-Varas, Alberto A. Amarilla, Daniel Watterson, Alejandro Rojas-Fernandez and Matthias M. Herth

Front. Nucl. Med., 2022, 2
DOI: 10.3389/fnume.2022.1033697

Trans-cyclooctene—a Swiss army knife for bioorthogonal chemistry: exploring the synthesis, reactivity, and applications in biomedical breakthroughs

Karuna Adhikari, Maarten Vanermen, Gustavo Da Silva, Tim Van den Wyngaert, Koen Augustyns and Filipe Elvas

EJNMMI radiopharm. chem., 2024, 9
DOI: 10.1186/s41181-024-00275-x

Applications of radiolabeled antibodies in neuroscience and neuro‐oncology

Ryan J. Pakula and Peter J. H. Scott

Labelled Comp Radiopharmac, 2023, 66, 269
DOI: 10.1002/jlcr.4049

Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics

Nathan Kauffman, James Morrison, Kevin O’Brien, Jinda Fan and Kurt R. Zinn

Pharmaceutics, 2023, 15, 1138
DOI: 10.3390/pharmaceutics15041138

Head-to-Head Comparison of the in Vivo Performance of Highly Reactive and Polar 18F-Labeled Tetrazines

Lars Hvass, Marius Müller, Markus Staudt, Rocio García-Vázquez, Tobias K. Gustavsson, Vladimir Shalgunov, Jesper T. Jørgensen, Umberto M. Battisti, Matthias M. Herth and Andreas Kjaer

Mol. Pharmaceutics, 2025, 22, 1911
DOI: 10.1021/acs.molpharmaceut.4c01129

The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review

Sahithi Talasila, Eric M. Teichner, Robert C. Subtirelu, David H. Xiang, Cyrus Ayubcha, Thomas Werner, Abass Alavi and Mona-Elisabeth Revheim

JCM, 2023, 12, 5491
DOI: 10.3390/jcm12175491

Copper-mediated radiochemistry: historical impact, current trends, and future possibilities

Gregory D. Bowden, Marius Müller, Matthias M. Herth, Melanie S. Sanford and Peter J. H. Scott

npj Imaging, 2025, 3
DOI: 10.1038/s44303-025-00087-x

The inverse electron demand Diels–Alder cycloaddition with carbon‐11 and fluorine‐18: A gateway to pretargeted imaging across the blood–brain barrier

Simon H. Zientek, Stephen Thompson, Selena Milicevic Sephton and Franklin I. Aigbirhio

Labelled Comp Radiopharmac, 2023, 66, 249
DOI: 10.1002/jlcr.4029

Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood–Brain Barrier

Tobias Gustavsson, Thomas Kustermann, Lars Hvass, Thomas E. Wuensche, Anne Skovsbo Clausen, Sophie Stotz, Vladimir Shalgunov, Sara Lopes van den Broek, Gitte M. Knudsen, Blanca Aldana, Elena Ferri, Giuseppe Cannazza, Jens Niewoehner, Luca Gobbi, Michael Honer, Umberto Maria Battisti, Andreas Kjaer and Matthias M. Herth

Mol. Pharmaceutics, 2025, 22, 7600
DOI: 10.1021/acs.molpharmaceut.5c01180

Emerging paradigms in bioorthogonal chemistry for future therapeutics

Maide Önder, Fatma Zehra Yılmaz, Zeynep Demirsoy and Gülcihan Gülseren

International Journal of Pharmaceutics, 2025, 685, 126236
DOI: 10.1016/j.ijpharm.2025.126236